Ligand validation:6OX5

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 6OX5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6OX5_SAH_A_601	68%	58%	0.151	0.964	0.89	0.71	2	-	0	0	100%	1
7W28_SAH_A_501	96%	32%	0.075	0.982	1.19	1.5	2	4	0	0	100%	1
6OX1_SAH_B_1001	85%	57%	0.113	0.978	0.96	0.71	1	-	2	0	100%	1
6MBK_SAH_B_1001	83%	26%	0.109	0.967	1.37	1.61	3	5	0	0	100%	1
6MBL_SAH_A_1001	83%	31%	0.109	0.967	1.17	1.55	3	5	0	0	100%	1
6OX4_SAH_B_601	82%	61%	0.119	0.976	0.81	0.68	1	-	0	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
4KRG_SAH_A_502	100%	25%	0.018	0.997	1.3	1.74	3	5	2	0	100%	1
2BB3_SAH_B_203	100%	9%	0.027	0.993	2.32	2.18	9	6	4	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.